In November, The New York Times reported that early monitoring of current and former heavy smokers with annual CT scans could identify lung cancer at an early stage and possibly save thousands of lives. A government-financed study found that these scans, which can be expensive, reduced the risk of death from lung cancer by 20 percent and appeared to reduce the risks of death from other causes, too. This scientific development raised the prospect that medical monitoring of smokers could be the next frontier in tobacco litigation.
But not in New York, at least for now.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
